GL1X · GenesisL1 explorer

Research workbench

Human SOD1 C57S mutant, as-isolated

Analyse Human SOD1 C57S mutant, as-isolated in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4MCM
Type
protein
Length
1,834 residues
Chains
12
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Superoxide dismutase [cu-zn]
EC
1.15.1.1
UniProt
P00441
Ligands
ZN, SO4
Pockets
18 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 4% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, D, F, G, H, I, J, K, LSuperoxide dismutase [cu-zn] (EC 1.15.1.1)protein1535% helix, 41% strandP00441
C, ESuperoxide dismutase [cu-zn] (EC 1.15.1.1)protein1523% helix, 38% strandP00441

Ligands and binding sites

  • ZN · Zinc ion · metal · 24 copies · chains A, B, C, D, E, F, G, H, I, J, K, L
  • SO4 · Sulfate ion · ion · 14 copies · chains A, B, D, F, C, E, G, H, J, L, I, K

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

18 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110920.770.79107SO4
211640.770.79113SO4
33030.630.8042empty
42790.630.8135empty
52640.610.8042empty

Interfaces

18 interfaces between chains.

  • A–B · 737 Ų buried · 4 hydrogen bonds · protein-protein
  • E–F · 722 Ų buried · 4 hydrogen bonds · protein-protein
  • G–H · 717 Ų buried · 4 hydrogen bonds · protein-protein
  • I–J · 696 Ų buried · 4 hydrogen bonds · protein-protein
  • C–D · 695 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 4MCM · Human SOD1 C57S Mutant, As-isolated · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.